- BIIB Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Biogen (BIIB) 10-K/A2002 FY Annual report (amended)
Filed: 3 Oct 03, 12:00am
EXHIBIT 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Annual Report on Form 10-K/A of IDEC Pharmaceuticals Corporation for the year ended December 31, 2002 (the "Report"), I, William H. Rastetter, Ph.D., Chairman of the Board and Chief Executive Officer of IDEC Pharmaceuticals Corporation, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
/s/ WILLIAM H. RASTETTER William H. Rastetter, Ph.D., Chairman of the Board and Chief Executive Officer | ||
October 2, 2003 |
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the accompanying Annual Report on Form 10-K/A of IDEC Pharmaceuticals Corporation for the year ended December 31, 2002 (the "Report"), I, Edward M. Rodriguez, Vice President, Finance and Controller of IDEC Pharmaceuticals Corporation, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
/s/ EDWARD M. RODRIGUEZ Edward M. Rodriguez, Vice President, Finance and Controller | ||
October 2, 2003 |